Sterne, Kessler, Goldstein & Fox PLLC

Biotechnology & Chemical and Trial & Appellate Practice Groups

Director, Co-Chair PTAB Trials practice

Over the course of her 29-year career, Eldora has gained extensive experience in inter partes patent matters, building on a strong foundation in patent prosecution.  Most recently, Eldora was designated lead patent strategist for the University of California on its ground-breaking CRISPR technology, and Eldora has led the University’s renewed interference proceedings.

Eldora’s practice also includes preparing and prosecuting patent applications; evaluating patent portfolios (e.g., for due diligence analyses, invalidity, non-infringement, or freedom-to-operate); counseling clients on intellectual property strategy, including Hatch-Waxman issues; and resolving inventorship disputes. She represents a variety of types of clients, including large multinational corporations, start-up companies, and not-for-profit organizations.

Eldora was named 2025 Patent Strategy Attorney of the Year in the DC Metro Region at the LMG Life Sciences awards, and is consistently recognized as a leading IP lawyer by Managing IP, Chambers, IAM Patent 1000, and LawDragon.

Eldora is a member of the firm’s Executive Committee, and she previously chaired the firm’s Professional Development Committee and the Diversity Committee. Eldora also serves as a member of the Diversity and Inclusion Committee for the Intellectual Property Owners Association, and she is a Co-chair of the Association’s Black IP Professionals Resource Group. She also previously served as a Member of the Board of Directors for Turning Point Academy Public Charter School in Maryland.

Georgetown University Law Center, J.D.; Cornell University, Ph.D. in biochemistry, molecular and cell biology; Haverford College, B.S. in biology.